{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:00:24Z","timestamp":1784588424559,"version":"3.55.0"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1212\/con.0000000000000708","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T14:58:34Z","timestamp":1553785114000},"page":"477-491","source":"Crossref","is-referenced-by-count":14,"title":["Counseling and Management of the Risks of Living With Epilepsy"],"prefix":"10.1212","volume":"25","author":[{"given":"Katherine","family":"Noe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","DOI":"10.17226\/13379","volume-title":"Institute of Medicine committee of the public health dimensions of the epilepsies. Epilepsy across the spectrum: promoting health and understanding","author":"England MJ","year":"2012","unstructured":"England MJ. Institute of Medicine committee of the public health dimensions of the epilepsies. Epilepsy across the spectrum: promoting health and understanding. Washington DC: National Academies Press, 2012."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb00166.x"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6974(95)00019-A"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31827b1ae0"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13769"},{"issue":"8","key":"e_1_3_1_7_2","first-page":"e107","article-title":"The prevalence of anxiety and associated factors in persons with epilepsy","volume":"58","author":"Pham T","year":"2017","unstructured":"Pham T Sauro KM Patten SB. The prevalence of anxiety and associated factors in persons with epilepsy. Epilepia 2017;58(8):e107\u2013e110. doi:10.1111\/epi.13817.","journal-title":"Epilepia"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70175-8"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-010-0861-y"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.05.028"},{"issue":"1","key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.yebeh.2008.04.005","article-title":"Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders","volume":"13","author":"Barry JJ","year":"2008","unstructured":"Barry JJ Ettinger AB Friel P. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008;13(suppl 1):S1\u2013S29. doi:10.1016\/j.yebeh.2008.04.005.","journal-title":"Epilepsy Behav"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.5042"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2014.05.011"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2011.06.007"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13651"},{"issue":"1","key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.62.1.23","article-title":"Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial","volume":"62","author":"Gilliam FG","year":"2004","unstructured":"Gilliam FG Fessler AJ Baker G. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004;62(1):23\u201327.","journal-title":"Neurology"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yebeh.2014.08.023","article-title":"Patterns and frequency of the treatment of depression in persons with epilepsy","volume":"39","author":"Fiest KM","year":"2014","unstructured":"Fiest KM Patten SB Altura KC. Patterns and frequency of the treatment of depression in persons with epilepsy. Epilepsy Behav 2014;39:54\u201364. doi:10.1016\/j.yebeh.2014.08.023.","journal-title":"Epilepsy Behav"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.09.023"},{"issue":"11","key":"e_1_3_1_19_2","first-page":"450","article-title":"A 102-center prospective study of seizure in association with bupropion","volume":"52","author":"Johnston JA","year":"1991","unstructured":"Johnston JA Lineberry CG Ascher JA. A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry 1991;52(11):450\u2013456.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-0327(85)90091-6","article-title":"The treatment of depression in patients with epilepsy. A double-blind trial","volume":"9","author":"Robertson MM","year":"1985","unstructured":"Robertson MM Trimble MR. The treatment of depression in patients with epilepsy. A double-blind trial. J Affect Disord 1985;9(2):127\u2013136. doi:10.1016\/0165-0327(85)90091-6.","journal-title":"J Affect Disord"},{"key":"e_1_3_1_21_2","first-page":"101","article-title":"Short-term efficacy of venlafaxine treating the depression in epilepsy patients","volume":"19","author":"Zhu S","year":"2004","unstructured":"Zhu S Luo L Gui Y. Short-term efficacy of venlafaxine treating the depression in epilepsy patients. Chin J Rehabil 2004:19:101.","journal-title":"Chin J Rehabil"},{"issue":"12","key":"e_1_3_1_22_2","first-page":"20","article-title":"A randomized controlled trial to evaluate the efficacy of paroxetine and doxepin in treating epileptic patients with depression","volume":"9","author":"Li W","year":"2005","unstructured":"Li W Ma D. A randomized controlled trial to evaluate the efficacy of paroxetine and doxepin in treating epileptic patients with depression. Chin J Clin Rehabil 2005;9(12):20\u201321.","journal-title":"Chin J Clin Rehabil"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2015.07.033"},{"issue":"3","key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10865-010-9299-z","article-title":"A randomized trial of a group based cognitive behavior therapy program for older adults with epilepsy: the impact on seizure frequency, depression and psychosocial well-being","volume":"34","author":"McLaughlin DP","year":"2011","unstructured":"McLaughlin DP McFarland K. A randomized trial of a group based cognitive behavior therapy program for older adults with epilepsy: the impact on seizure frequency, depression and psychosocial well-being. J Behav Med 2011;34(3):201\u2013207. doi:10.1007\/s10865-010-9299-z.","journal-title":"J Behav Med"},{"issue":"3","key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.yebeh.2011.01.017","article-title":"Long-term outcomes from the PEARLS randomized trial for the treatment of depression in patients with epilepsy","volume":"20","author":"Chaytor N","year":"2011","unstructured":"Chaytor N Ciechanowski P Miller JW. Long-term outcomes from the PEARLS randomized trial for the treatment of depression in patients with epilepsy. Epilepsy Behav 2011;20(3):545\u2013549. doi:10.1016\/j.yebeh.2011.01.017.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/16506073.2014.892530","article-title":"Cognitive behaviour therapy to improve mood in people with epilepsy: a randomised controlled trial","volume":"43","author":"Gandy M","year":"2014","unstructured":"Gandy M Sharpe L Nicholson Perry K. Cognitive behaviour therapy to improve mood in people with epilepsy: a randomised controlled trial. Cognitive Behav Therapy 2014;43(2):153\u2013166. doi:10.1080\/16506073.2014.892530.","journal-title":"Cognitive Behav Therapy"},{"issue":"2","key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1037\/a0038404","article-title":"Expanding the efficacy of Project UPLIFT: distance delivery of mindfulness-based depression prevention to people with epilepsy","volume":"83","author":"Thompson NJ","year":"2015","unstructured":"Thompson NJ Patel AH Selwa LM. Expanding the efficacy of Project UPLIFT: distance delivery of mindfulness-based depression prevention to people with epilepsy. J Consult Clin Psychol 2015;83(2):304\u2013313. doi:10.1037\/a0038404.","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.yebeh.2003.08.009","article-title":"Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants","volume":"4","author":"K\u00fchn KU","year":"2003","unstructured":"K\u00fchn KU Quednow BB Thiel M. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 2003;4(6):674\u2013679. doi:10.1016\/j.yebeh.2003.08.009.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/ebeh.2000.0050","article-title":"The use of sertraline in patients with epilepsy: is it safe?","volume":"1","author":"Kanner AM","year":"2000","unstructured":"Kanner AM Kozak AM Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 2000;1(2):100\u2013105. doi:10.1006\/ebeh.2000.0050.","journal-title":"Epilepsy Behav"},{"issue":"6","key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1006\/ebeh.2000.0123","article-title":"Treatment of interictal depression with citalopram in patients with epilepsy","volume":"1","author":"Hovorka J","year":"2000","unstructured":"Hovorka J Herman E Nemcova I. Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav 2000;1(6):444\u2013447. doi:10.1006\/ebeh.2000.0123.","journal-title":"Epilepsy Behav"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200405000-00009"},{"issue":"11","key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1528-1167.2011.03276.x","article-title":"International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy","volume":"52","author":"Kerr MP","year":"2011","unstructured":"Kerr MP Mensah S Besag F. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011;52(11):2133\u20132138. doi:10.1111\/j.1528-1167.2011.03276.x.","journal-title":"Epilepsia"},{"issue":"11","key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2165\/00003495-200868110-00003","article-title":"Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs","volume":"68","author":"Miller JM","year":"2008","unstructured":"Miller JM Kustra RP Vuong A. Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs. Drugs 2008;68(11):1493\u20131509.","journal-title":"Drugs"},{"key":"e_1_3_1_34_2","unstructured":"Statistical review and evaluation: antiepileptic drugs and suicidality. fda.gov\/downloads\/drugs\/drugsafety\/postmarketdrugsafetyinformationforpatientsandproviders\/ucm192556.pdf. Published May 23 2008. Accessed January 28 2019."},{"issue":"2","key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1528-1157.1997.tb01102.x","article-title":"Patient-validated content of epilepsy-specific quality-of-life measurement","volume":"38","author":"Gilliam F","year":"1997","unstructured":"Gilliam F Kuzniecky R Faught E. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997;38(2):233\u2013236. doi:10.1111\/j.1528-1157.1997.tb01102.x.","journal-title":"Epilepsia"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ea157e"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2015.04.016"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01051.x"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2010.06.041"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13804"},{"issue":"9","key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.0b013e31820e7b3b","article-title":"Motor vehicle accidents, suicides, and assaults in epilepsy: a population-based study","volume":"76","author":"Kwon C","year":"2011","unstructured":"Kwon C Liu M Quan H. Motor vehicle accidents, suicides, and assaults in epilepsy: a population-based study. Neurology 2011;76(9):801\u2013806. doi:10.1212\/WNL.0b013e31820e7b3b.","journal-title":"Neurology"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000138590.00074.9A"},{"issue":"26","key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.15585\/mmwr.mm6526e1","article-title":"Vital signs: motor vehicle injury prevention \u2013 United States and 19 comparison countries","volume":"65","author":"Sauber-Schatz EK","year":"2016","unstructured":"Sauber-Schatz EK Ederer DJ Dellinger AM Baldwin GT. Vital signs: motor vehicle injury prevention \u2013 United States and 19 comparison countries. MMWR Morb Mortal Wkly Rep 2016;65(26):672\u2013677. doi:10.15585\/mmwr.mm6526e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2015.11.005"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.4065\/78.7.819"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000259514.85579.e0"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2008.12.020"},{"issue":"2","key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/CON.0000000000000714","article-title":"Driving and epilepsy: ethical, legal, and health care policy challenges","volume":"25","author":"Kass JS","year":"2019","unstructured":"Kass JS Rose RV. Driving and epilepsy: ethical, legal, and health care policy challenges. Continuum 2019;25(2, Epilepsy):537\u2013542. doi:10.1212\/CON.0000000000000714.","journal-title":"Continuum"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.18701.x"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.02.031"},{"issue":"2","key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0013-9580.2005.23804.x","article-title":"Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database","volume":"46","author":"Souverein PC","year":"2005","unstructured":"Souverein PC Webb DJ Petri H. Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia 2005;46(2):304\u2013310. doi:10.1111\/j.0013-9580.2005.23804.x.","journal-title":"Epilepsia"},{"issue":"9","key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1212\/01.wnl.0000210503.89488.88","article-title":"Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy","volume":"66","author":"Souverein PC","year":"2006","unstructured":"Souverein PC Webb DJ Weil JG. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology 2006;66(9):1318\u20131324. doi:10.1212\/01.wnl.0000210503.89488.88.","journal-title":"Neurology"},{"issue":"6","key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.seizure.2010.04.013","article-title":"Fractures in epilepsy children","volume":"19","author":"Gniatkowska-Nowakowska A","year":"2010","unstructured":"Gniatkowska-Nowakowska A. Fractures in epilepsy children. Seizure 2010;19(6):324\u2013325. doi:10.1016\/j.seizure.2010.04.013.","journal-title":"Seizure"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31825f0466"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2012.10.002"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(00)00126-1"},{"issue":"11","key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.0013-9580.2004.18804.x","article-title":"Fracture risk associated with use of antiepileptic drugs","volume":"45","author":"Vestergaard P","year":"2004","unstructured":"Vestergaard P Rejnmark L Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004;45(11):1330\u20131337. doi:10.1111\/j.0013-9580.2004.18804.x.","journal-title":"Epilepsia"},{"issue":"10","key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/01.wnl.0000324919.86696.a9","article-title":"Antiepileptic drug use and rates of hip bone loss in older men: a prospective study","volume":"71","author":"Ensrud KE","year":"2008","unstructured":"Ensrud KE Walczak TS Blackwell TL. Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology 2008;71(10):723\u2013730. doi:10.1212\/01.wnl.0000324919.86696.a9.","journal-title":"Neurology"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2014.06.008"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12351"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13604"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03661.x"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000319693.10338.b9"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2004.05.004"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003685"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02952.x"},{"issue":"1","key":"e_1_3_1_67_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.seizure.2012.09.017","article-title":"Are we discussing SUDEP?\u2013A retrospective case note analysis","volume":"22","author":"Waddell B","year":"2013","unstructured":"Waddell B McColl K Turner C. Are we discussing SUDEP?\u2013A retrospective case note analysis. Seizure 2013;22(1):74\u201376. doi:10.1016\/j.seizure.2012.09.017.","journal-title":"Seizure"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.12.020"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.02.027"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.09.040"},{"key":"e_1_3_1_71_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yebeh.2016.09.022","article-title":"SUDEP: what do adult patients want to know?","volume":"64","author":"RamachandranNair R","year":"2016","unstructured":"RamachandranNair R Jack SM. SUDEP: what do adult patients want to know? Epilepsy Behav 2016;64(pt A):195\u2013199. doi:10.1016\/j.yebeh.2016.09.022.","journal-title":"Epilepsy Behav"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02506.x"},{"issue":"11","key":"e_1_3_1_73_2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/aje\/kwh140","article-title":"Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland","volume":"159","author":"Artama M","year":"2004","unstructured":"Artama M Isoj\u00e4rvi J Raitanen J Auvinen A. Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. Am J Epidemiol 2004;159(11):1057\u20131063. doi:10.1093\/aje\/kwh140.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"e_1_3_1_74_2","first-page":"1","article-title":"Epilepsy surveillance among adults\u201319 states, behavioral risk factor surveillance system, 2005","volume":"57","author":"Kobau R","year":"2008","unstructured":"Kobau R Zahran H Thurman DJ. Epilepsy surveillance among adults\u201319 states, behavioral risk factor surveillance system, 2005. MMWR Surveil Summ 2008;57(6):1\u201320.","journal-title":"MMWR Surveil Summ"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2013.07.002"},{"issue":"9","key":"e_1_3_1_76_2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1528-1167.2009.02507.x","article-title":"Genetic risk perception and reproductive decision making among people with epilepsy","volume":"51","author":"Helbig KL","year":"2010","unstructured":"Helbig KL Bernhardt BA Conway LJ. Genetic risk perception and reproductive decision making among people with epilepsy. Epilepsia 2010;51(9):1864\u20131867. doi:10.1111\/j.1528-1167.2009.02507.x.","journal-title":"Epilepsia"},{"issue":"3","key":"e_1_3_1_77_2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/brain\/awt368","article-title":"Familial risk of epilepsy: a population-based study","volume":"137","author":"Peljto AL","year":"2004","unstructured":"Peljto AL Barker-Cummings C Vasoli VM. Familial risk of epilepsy: a population-based study. Brain 2004;137(pt 3):795\u2013805. doi:10.1093\/brain\/awt368.","journal-title":"Brain"},{"issue":"2","key":"e_1_3_1_78_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1212\/CON.0000000000000723","article-title":"Evaluation of seizure etiology from routine testing to genetic evaluation","volume":"25","author":"Schuele SU","year":"2019","unstructured":"Schuele SU. Evaluation of seizure etiology from routine testing to genetic evaluation. Continuum 2019;25(2, Epilepsy):322\u2013342. doi:10.1212\/CON.0000000000000723.","journal-title":"Continuum"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02429.x"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.60"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201904000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:07:38Z","timestamp":1752156458000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1212\/CON.0000000000000708"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000708","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}